Non-invasive prediction of axillary lymph node dissection exemption in breast cancer patients post-neoadjuvant therapy: A radiomics and deep learning analysis on longitudinal DCE-MRI data. [PDF]
Yu Y+6 more
europepmc +1 more source
De-Escalation of Axillary Surgery in Clinically Node-Positive Breast Cancer Patients Treated with Neoadjuvant Therapy: Comparative Long-Term Outcomes of Sentinel Lymph Node Biopsy versus Axillary Lymph Node Dissection. [PDF]
Tinterri C+4 more
europepmc +1 more source
Is Sentinel Lymph Node Biopsy a Viable Alternative to Axillary Lymph Node Dissection in Breast Carcinoma Patients Who Have Received Neo-Adjuvant Chemotherapy? [PDF]
Sulthana R, Singh A.
europepmc +1 more source
Quality of Life After Axillary Lymph Node Dissection Among Racial and Ethnic Minority Women.
Heller DR+5 more
europepmc +1 more source
Oncological Safety of Skipping Axillary Lymph Node Dissection in Patients with Clinical N0, Sentinel Node-Positive Breast Cancer Undergoing Total Mastectomy. [PDF]
Chun JW+6 more
europepmc +1 more source
A promising step forward: early results from a randomized clinical trial support the efficacy of immediate lymphatic reconstruction following axillary lymph node dissection. [PDF]
Yakaback S, Bains I, Temple-Oberle C.
europepmc +1 more source
Reevaluating Axillary Lymph Node Dissection in Total Mastectomy for Low Axillary Burden Breast Cancer: Insights from a Meta-Analysis including the SINODAR-ONE Trial. [PDF]
Alamoodi M+4 more
europepmc +1 more source
Total Sealing Technique (TST) with a bipolar vessel sealing system reduces lymphorrhea and seroma formation for axillary lymph node dissection in primary breast cancer. [PDF]
Ikeda N+4 more
europepmc +1 more source
Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clinical N2 achieving pathological complete response after neoadjuvant therapy: Is it necessary? [PDF]
Guo X+26 more
europepmc +1 more source